Northumberland construction pioneer Merit Health has been awarded a contract to deliver a £30m manufacturing facility for Piramal Pharma Solutions.
The Cramlington offsite construction specialist will build the pharmaceutical firm’s new Antibody Drug Conjugate (ADC) plant for its Grangemouth site, and up to 80% of the technical building will be crafted at Merit’s base in the North East.
Piramal offers drug development and manufacturing solutions to global pharmaceutical companies, developing and manufacturing product including ADCs which are currently used in targeted cancer treatment, but have the potential for further applications. Demand for ADC therapies is in high demand, so Piramal need a fast-track solution to boost their manufacturing capabilities quickly.
